Xenon Pharmaceuticals Inc (XENE) - Forvard P/S multiplikatori

Xenon Pharmaceuticals Inc (XENE) grafik logotipi

Xenon Pharmaceuticals (XENE) rahbariyati yangi molekulalar uchun yakuniy bosqich sinovlari natijalarini kutmoqda, bunda tadqiqot va ishlanmalar (R&D) xarajatlari allaqachon narxga kiritilgan. GURU.Markets platformasidagi biznesning oldingi P/S ko'rsatkichi ushbu strategiyaning natijalarini namoyish etadi, bunda 710.90 ushbu metrikaning joriy qiymatini ko'rsatadi. Model autsorsingga asoslangan ishlab chiqarish va logistikaga tayanadi, epilepsiya segmentidagi kuchli narx belgilash imkoniyati esa noyob terapiyadan aniq daromadni ta'minlaydi.

XENE Xenon: Sotuvga nisbatan forvard narx 04.07.2022 - 08.05.2026 oraligʻida

Xenon Pharmaceuticals (XENE) kompaniyasi koʻrsatkichlari kesimi va tahlili

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning barcha koʻrsatkichlari tahlili:xenon-pharma.com XENE
Xenon Corp tovar namunasi

Xarajatlar va biznes sifati o'rtasidagi muvozanatni topish uchun joriy bozor kapitalizatsiyasining kutilayotgan daromadga nisbatidan foydalaning, bu kelajakdagi savdo o'sishi uchun qanchalik ortiqcha to'lov qilinganini aniqlaydi. GURU.Markets platformasida forward P/S koeffitsiyenti tendentsiyasi Xenon Pharmaceuticals (XENE) rahbariyatining nevrologik portfeli bo'yicha klinik rejalarini amalga oshirishdagi intizomiga bo'lgan bozor ishonchini aks ettiradi va bu emitentning potentsiali uchun to'lanayotgan premium asosli yoki yo'qligini baholash imkonini beradi.

Raqobatchilar tahlili

Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - Forvard P/S multiplikatori|CPRX: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori DNLI|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Harmony Biosciences|Biohaven Ltd - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Praxis Corp PRAX|AVXL: Forvard P/S multiplikatori|CBLL (ceribell.com) - Narxning prognoz qilingan daromadga nisbati|PRTA (Prothena Corporation) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori alector.com (ALEC)|Narxning prognoz qilingan daromadga nisbati Annexon, Inc. (ANNX)|OMER - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Voyager Therapeutics Inc - Forvard P/S multiplikatori|Neumora (NMRA) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|TVGN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ACOG (Alpha Cognition Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori cogrx.com (CGTX)|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cassava Sciences|Forvard P/S multiplikatori ASRT (Assertio Holdings)|COYA - Forvard narx/daromad multiplikatori|vistagen.com - Forvard P/S multiplikatori|OVID: Narxning prognoz qilingan daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning prognoz qilingan daromadga nisbati|CervoMed Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PEPG (PepGen Inc)|Forvard P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori